beta-DIHYDROFURAN DERIVING COMPOUND, METHOD FOR PRODUCING beta-DIHYDROFURAN DERIVING COMPOUND OR beta-TETRAHYDROFURAN DERIVING COMPOUND, beta-GLYCOSIDE COMPOUND, METHOD FOR PRODUCING beta GLYCOSIDE COMPOUND, AND METHOD FOR PRODUCING 4'-ETHYNYL D4T AND ANALOGUE COMPOUNDS THEREOF
申请人:Iriyama Yusuke
公开号:US20120322995A1
公开(公告)日:2012-12-20
The invention provides a process for producing a β-dihydrofuran derivative represented by formula (1) or a β-tetrahydrofuran derivative represented by formula (4), characterized in that the process includes causing a dialkyl dicarbonate, a diaralkyl dicarbonate, or a halide to act on a diol compound represented by formula (2) or (3). The invention also provides a process for producing 4′-ethynyl-2′,3′-didehydro-3′-deoxythymidine or an analog thereof, the process including glycosylation and deprotection.
作者:A. B. Ouryupin、I. A. Rakhov、V. A. Kolesova、P. V. Petrovskii、T. A. Mastryukova、M. I. Kabachnik
DOI:10.1007/bf00696723
日期:1995.11
The phosphorylation ofN-trimethylsilyllactams by phosphorus(III) acid chlorides results in correspondingN-phosphinolactams in high yields. The derivatives thus obtained have been used in the synthesis ofN-phosphoryl- andN-thiophosphoryllactams. The reversibility of the reaction of phosphinolactams has been established.
Synthesis and study of the antiinflammatory and analgesic activity of some phosphinic acid esters
作者:B. K. Beznosko、V. M. Usanova、L. V. Zhuravleva、V. E. Baulin、A. N. Yarkevich、V. Kh. Syundyukova、E. N. Tsvetkov
DOI:10.1007/bf02464249
日期:1997.12
in its activity with acetylsalicylic acid. In contrast to the latter acid, this oxide produces no ulcerogenic effect even at a dose of 1/3 LD50. Therefore, it was of interest to continue the search for new antiinflammatory and analgesic agents in the series of phosphoryl-containing compounds. The purpose of this work was to study the antiinflammatory and analgesic properties and the acute toxicity of
Synthesis and Biological Action of Novel 4-Position-Modified Derivatives of <scp>d</scp>-<i>myo</i>-Inositol 1,4,5-Trisphosphate
作者:Davide Bello、Tashfeen Aslam、Geert Bultynck、Alexandra M. Z. Slawin、H. Llewelyn Roderick、Martin D. Bootman、Stuart J. Conway
DOI:10.1021/jo070611a
日期:2007.7.1
The design of a range of 4-position-modified d-myo-inositol1,4,5-trisphosphate derivatives is described. The enantioselective synthesis of these compounds is reported, along with initial biological analysis, which indicates that these compounds do not act as d-myo-inositol1,4,5-trisphosphate receptor agonists or antagonists.